首页|基于伏邪理论从"寒热-痰瘀-虚劳"角度分期辨治肺痿

基于伏邪理论从"寒热-痰瘀-虚劳"角度分期辨治肺痿

扫码查看
原文链接
  • 国家科技期刊平台
  • NETL
  • NSTL
  • 万方数据
肺痿是以肺叶痿弱为特征的慢性肺脏虚损性疾病,以咳唾涎沫、气短为主症,与现代医学特发性肺纤维化(IPF)相类似.临床以咳嗽、进行性呼吸困难、喘促胸闷为主要表现,甚则呼吸衰竭危及生命.肺痿属于古代疑难杂症,现代医学治疗亦十分棘手.汉代张机从"寒热-痰瘀-虚劳"的角度阐述了肺痿的主要病机,开创了治疗肺痿之先河.肺痿的病因病机复杂多样,病情迁延难愈,与伏邪理论"伏而不发"的特点不谋而合.因此,基于伏邪理论,结合中西医病机特点,进一步探讨肺痿早期、进展期、终末期3个阶段的分期论治思路,以期为肺痿不同阶段论治提供新的辨证论治思路.
Treatment of Lung Atrophy from the Perspective of Cold Heat-phlegm Stasis-consumptive Disease Based on the Theory of Latent Pathogen
Lung atrophy is a chronic consumptive lung disease characterized by atrophic lung lobes,with cough,salivation,and shortness of breath as the primary symptoms,similar to idiopathic pulmonary fibrosis in modem medicine.The main clinical mani-festations of lung atrophy are cough,progressive dyspnea,shortness of breath,chest tightness,and even respiratory failure threaten-ing life.Lung atrophy was a difficult miscellaneous condition in ancient times,and it is still problematic today.Zhang Zhongjing in the Han Dynasty explained the main pathogenesis of lung atrophy from the changes of cold heat-phlegm stasis-consumptive disease and pioneered the treatment of this disease.The complex and diverse etiology and pathogenesis and the lingering symptoms of lung atrophy coincide with the theory of latent pathogen.According to the theory of latent pathogen,we explored the idea of staged treat-ment of lung atrophy at early,advanced and terminal stages by combining the pathogenesis characteristics in TCM and Western medicine,aiming to provide a new idea for the syndrome differentiation and treatment of lung atrophy at different stages.

Latent pathogenLung atrophyIdiopathic pulmonary fibrosisSynopsis of the Golden Chamber(Jin Gui Yao Lue)Staged diagnosis and treatmentEtiology and pathogenesisCold and heat in the lungPhlegm combined with stasis

陶旺、王培屹、孙杰、张冰冰、张晓虹、张诗晓

展开 >

广州中医药大学第一临床医学院,广州,510499

昆明医科大学第二附属医院,昆明,650106

广州中医药大学第一附属医院,广州,510405

广东省中医临床研究院,广州,510802

展开 >

伏邪 肺痿 特发性肺纤维化 《金匮要略》 分期辨治 病因病机 寒热伏肺 痰瘀互结

国家自然科学基金项目

82374362

2024

10.3969/j.issn.1673-7202.2024.08.010

世界中医药
世界中医药学会联合会

世界中医药

CSTPCDCHSSCD北大核心
影响因子：1.266
ISSN：1673-7202
年,卷(期)：2024.19(8)
  • 25